TRIGG, TIMOTHY ELLIOT,WALSH, JOHN DESMOND,SCHOBER, PAUL ADAM
申请号：
CA2264562
公开号：
CA2264562C
申请日:
1997.09.01
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
A pharmaceutical and/or veterinary formulation for sustained release of apeptide agonist or analogue, comprising about 2-15 % (w/w) of at least onepeptide agonist or analogue other than deslorelin (on an active basis), about0.5-3.5 % (w/w) lecithin and the balance sterin. The formulation preferablycomprises a GnRH agonist or analogue and is used for the treatment of variousconditions where suppression of sex hormone levels is beneficial, particularlyprostate cancer, ovarian and breast cancer, and benign prostatic hyperplasiain dogs.
